Nicotinamide riboside kinase structures reveal new pathways to NAD+.
The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is induced in response to nerve damage and promotes replicative life span in yeast, converts nicotinamide riboside to nicotinamide adenine dinucleotide (NAD+) by phosphorylation and adenylylation. Crystal structures of human Nrk1 bound...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e381eb8f8a6473f955a9c049c6e9369 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6e381eb8f8a6473f955a9c049c6e9369 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6e381eb8f8a6473f955a9c049c6e93692021-12-02T19:54:31ZNicotinamide riboside kinase structures reveal new pathways to NAD+.1544-91731545-788510.1371/journal.pbio.0050263https://doaj.org/article/6e381eb8f8a6473f955a9c049c6e93692007-10-01T00:00:00Zhttps://doi.org/10.1371/journal.pbio.0050263https://doaj.org/toc/1544-9173https://doaj.org/toc/1545-7885The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is induced in response to nerve damage and promotes replicative life span in yeast, converts nicotinamide riboside to nicotinamide adenine dinucleotide (NAD+) by phosphorylation and adenylylation. Crystal structures of human Nrk1 bound to nucleoside and nucleotide substrates and products revealed an enzyme structurally similar to Rossmann fold metabolite kinases and allowed the identification of active site residues, which were shown to be essential for human Nrk1 and Nrk2 activity in vivo. Although the structures account for the 500-fold discrimination between nicotinamide riboside and pyrimidine nucleosides, no enzyme feature was identified to recognize the distinctive carboxamide group of nicotinamide riboside. Indeed, nicotinic acid riboside is a specific substrate of human Nrk enzymes and is utilized in yeast in a novel biosynthetic pathway that depends on Nrk and NAD+ synthetase. Additionally, nicotinic acid riboside is utilized in vivo by Urh1, Pnp1, and Preiss-Handler salvage. Thus, crystal structures of Nrk1 led to the identification of new pathways to NAD+.Wolfram TempelWael M RabehKatrina L BoganPeter BelenkyMarzena WojcikHeather F SeidleLyudmila NedyalkovaTianle YangAnthony A SauveHee-Won ParkCharles BrennerPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Biology, Vol 5, Iss 10, p e263 (2007) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Biology (General) QH301-705.5 |
spellingShingle |
Biology (General) QH301-705.5 Wolfram Tempel Wael M Rabeh Katrina L Bogan Peter Belenky Marzena Wojcik Heather F Seidle Lyudmila Nedyalkova Tianle Yang Anthony A Sauve Hee-Won Park Charles Brenner Nicotinamide riboside kinase structures reveal new pathways to NAD+. |
description |
The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is induced in response to nerve damage and promotes replicative life span in yeast, converts nicotinamide riboside to nicotinamide adenine dinucleotide (NAD+) by phosphorylation and adenylylation. Crystal structures of human Nrk1 bound to nucleoside and nucleotide substrates and products revealed an enzyme structurally similar to Rossmann fold metabolite kinases and allowed the identification of active site residues, which were shown to be essential for human Nrk1 and Nrk2 activity in vivo. Although the structures account for the 500-fold discrimination between nicotinamide riboside and pyrimidine nucleosides, no enzyme feature was identified to recognize the distinctive carboxamide group of nicotinamide riboside. Indeed, nicotinic acid riboside is a specific substrate of human Nrk enzymes and is utilized in yeast in a novel biosynthetic pathway that depends on Nrk and NAD+ synthetase. Additionally, nicotinic acid riboside is utilized in vivo by Urh1, Pnp1, and Preiss-Handler salvage. Thus, crystal structures of Nrk1 led to the identification of new pathways to NAD+. |
format |
article |
author |
Wolfram Tempel Wael M Rabeh Katrina L Bogan Peter Belenky Marzena Wojcik Heather F Seidle Lyudmila Nedyalkova Tianle Yang Anthony A Sauve Hee-Won Park Charles Brenner |
author_facet |
Wolfram Tempel Wael M Rabeh Katrina L Bogan Peter Belenky Marzena Wojcik Heather F Seidle Lyudmila Nedyalkova Tianle Yang Anthony A Sauve Hee-Won Park Charles Brenner |
author_sort |
Wolfram Tempel |
title |
Nicotinamide riboside kinase structures reveal new pathways to NAD+. |
title_short |
Nicotinamide riboside kinase structures reveal new pathways to NAD+. |
title_full |
Nicotinamide riboside kinase structures reveal new pathways to NAD+. |
title_fullStr |
Nicotinamide riboside kinase structures reveal new pathways to NAD+. |
title_full_unstemmed |
Nicotinamide riboside kinase structures reveal new pathways to NAD+. |
title_sort |
nicotinamide riboside kinase structures reveal new pathways to nad+. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2007 |
url |
https://doaj.org/article/6e381eb8f8a6473f955a9c049c6e9369 |
work_keys_str_mv |
AT wolframtempel nicotinamideribosidekinasestructuresrevealnewpathwaystonad AT waelmrabeh nicotinamideribosidekinasestructuresrevealnewpathwaystonad AT katrinalbogan nicotinamideribosidekinasestructuresrevealnewpathwaystonad AT peterbelenky nicotinamideribosidekinasestructuresrevealnewpathwaystonad AT marzenawojcik nicotinamideribosidekinasestructuresrevealnewpathwaystonad AT heatherfseidle nicotinamideribosidekinasestructuresrevealnewpathwaystonad AT lyudmilanedyalkova nicotinamideribosidekinasestructuresrevealnewpathwaystonad AT tianleyang nicotinamideribosidekinasestructuresrevealnewpathwaystonad AT anthonyasauve nicotinamideribosidekinasestructuresrevealnewpathwaystonad AT heewonpark nicotinamideribosidekinasestructuresrevealnewpathwaystonad AT charlesbrenner nicotinamideribosidekinasestructuresrevealnewpathwaystonad |
_version_ |
1718375905362968576 |